![Cognitive dysfunction in patients with multiple sclerosis treated with different types of interferon beta: A randomized clinical trial - Journal of the Neurological Sciences Cognitive dysfunction in patients with multiple sclerosis treated with different types of interferon beta: A randomized clinical trial - Journal of the Neurological Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2048714103/2058476486/gr1.jpg)
Cognitive dysfunction in patients with multiple sclerosis treated with different types of interferon beta: A randomized clinical trial - Journal of the Neurological Sciences
![Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020 | SpringerLink Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020 | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40265-021-01526-w/MediaObjects/40265_2021_1526_Fig1_HTML.png)
Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020 | SpringerLink
![Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives - The Lancet Neurology Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2023595965/2043806987/gr1.jpg)
Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives - The Lancet Neurology
Adaptive clinical trials incorporating treatment selection and evaluation: methodology and application in progressive multiple sclerosis - WRAP: Warwick Research Archive Portal
![2019 Secondary Progressive Multiple Sclerosis (SPMS) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 2019 Secondary Progressive Multiple Sclerosis (SPMS) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025](http://www.researchandmarkets.com/product_images/8105/8105659_500px_jpg/2019_secondary_progressive_multiple_sclerosis_spms_clinical_trials_guide_companies_drugs_phases_subjects_current_status_and_outlook_to_2025.jpg)
2019 Secondary Progressive Multiple Sclerosis (SPMS) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
![Multiple Sclerosis-Secondary Progressive MultiArm Randomisation Trial... | Download Scientific Diagram Multiple Sclerosis-Secondary Progressive MultiArm Randomisation Trial... | Download Scientific Diagram](https://www.researchgate.net/publication/327332561/figure/fig1/AS:665522538545158@1535684346832/Multiple-Sclerosis-Secondary-Progressive-MultiArm-Randomisation-Trial-participant.png)
Multiple Sclerosis-Secondary Progressive MultiArm Randomisation Trial... | Download Scientific Diagram
![Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting | Nature Reviews Neurology Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting | Nature Reviews Neurology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrneurol.2017.171/MediaObjects/41582_2018_Article_BFnrneurol2017171_Fig1_HTML.jpg)